Results 31 to 40 of about 109 (102)

QUALITY OF LIFE AND ITS DYNAMICS IN PATIENTS WITH ATRIAL FIBRILLATION AFTER LEAVING THE INTERNATIONAL CLINICAL TRIAL

Рациональная фармакотерапия в кардиологии, 2015
Aim. To study changes in quality of life (QoL) in patients with atrial fibrillation (AF) treated with warfarin after leaving the international clinical trial. Material and Methods.
E. L. Artanova, L. E. Kon'shina, I. M. Sokolov, Y. G. Shvarts   +3 more
doaj   +1 more source

COMPARISON OF DIRECT COSTS OF DABIGATRAN AND WARFARIN THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION DURING PREPARATION FOR ELECTIVE CARDIOVERSION IN THE REAL CLINICAL PRACTICE

Рациональная фармакотерапия в кардиологии, 2015
Aim. To compare direct medical costs of dabigatran and warfarin therapy in patients with non-valvular atrial fibrillation (NVAF) during preparation for elective cardioversion. Material and methods.
L. E. Kuvshinova, N. V. Furman, P. V. Dolotovskaya, Ya. P. Dovgalevsky   +3 more
doaj   +1 more source

VARFARIN DOSE REGIME APPROACHS BASED ON PHARMACOGENETICS TEST RESULTS: REAL POSSIBILITY TO OPTIMIZE THE PHARMACOTHERAPY

Рациональная фармакотерапия в кардиологии, 2015
Indirect anticoagulants effectively prevent thromboembolic complications in patients with high risk of their development. It was proven in multicenter controlled studies.
D. A. Sychev, I. M. Antonov, S. V. Zagrebin, N. A. Gasanov, V. G. Kukes   +4 more
doaj   +1 more source

Dabigatran etexilate in the prevention of cardioembolic complications in patients with non-valvular atrial fibrillation

Медицинский совет, 2014
Cardioembolic complications such as ischemic stroke and non-central nervous system venous thrombosis are among the most serious consequences of atrial fibrillation (AF) [1, 2].
IS Yavelov
doaj   +1 more source

The problem of choosing an anticoagulant for stroke prevention in patients with atrial fibrillation

Медицинский совет, 2014
The article is a literature review on the problem of thromboembolic complications in non-valvular atrial fibrillation, the peculiarities of anticoagulant therapy and challenges associated with the selection of drugs for stroke prevention.
EL Dolgova, IM Sokolov, YG Schwarz
doaj   +1 more source

Pulmonary embolism: inpatient and outpatient treatment

Медицинский совет, 2014
Pulmonary embolism (PE) is a rather common emergency situation. Occlusion of pulmonary arteries of different calibre may result in critical condition, shock, sudden death, while in a number of patients who survived thromboembolism it may lead to long ...
GE Gendlin, AV Melekhov, GI Storozhakov, EE Ryazantseva   +3 more
doaj   +1 more source

Pharmacoeconomic evaluation of treating acute venous thromboembolism with rivaroxaban in the inpatient setting

Медицинский совет, 2014
Cost reduction associated with the use of rivaroxaban compared with the enoxaparin + warfarin combination for for deep vein thrombosis and pulmonary thromboembolism when treated in the inpatient setting.
MV Avksentyeva, OV Shatalova
doaj   +1 more source

Antikoagulyantnaya terapiya u patsientov s fibrillyatsiey predserdiy: retrospektivnoe issledovanie

КардиоСоматика, 2013
Цель. Оценить качество антикоагулянтной терапии у пациентов с фибрилляций предсердий (ФП) неклапанной этиологии.Методы. Проведен ретроспективный анализ амбулаторных карт и историй болезни 304 пациентов с ФП, проходивших лечение в ФГБУЗ «СМКЦ им.
E. L Chumak, E. V Serdechnaya
doaj  

ADVANTAGES AND DISADVANTAGES OF WARFARIN AND PRADAXA THERAPY FOR VENOUS THROMBOEMBOLISM

Вестник хирургии имени И.И. Грекова, 2018
An analysis of complex examination of 110 patients with venous thromboembolism was made. The patients were separated into 2 groups. The first group included 60 patients, who had the start heparin therapy during 7 days with the following 6-month warfarin ...
B. S. Sukovatykh, L. N. Belikov, O. F. Savchuk, M. B. Sukovatykh   +3 more
doaj   +1 more source

[Russian eligibility criteria prescribing menopausal hormonal hormones therapy for patients with cardiovascular and metabolic diseases. Consensus document of the Russian Cardiological Society, Russian Society of Obstetricians and Gynecologists, Russian Association of Endocrinologists, Eurasian Association of Therapists, Association of Phlebologists of Russia]. [PDF]

Probl Endokrinol (Mosk), 2023
Shlyakhto EV, Sukhikh GT, Serov VN, Dedov II, Arutyunov GP, Suchkov IA, Orlova YA, Andreeva EN, Yureneva SV, Yavelov IS, Yarmolinskaya MI, Villevalde SV, Grigoryan OR, Dudinskaya EN, Ilyukhin EA, Koziolova NA, Sergienko IV, Smetnik AA, Tapilskaya NI.   +18 more
europepmc   +1 more source